Clinical trialNCT06457503RecruitingPhase 4Interventional

A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

SponsorCoherus Oncology, Inc.Enrollment100Nasopharyngeal Cancer Recurrent

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study aims to investigate toripalimab with chemotherapy in participants with nasopharyngeal cancer.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Study Director
Coherus Oncology
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Princess Margaret Cancer Centre
Toronto, Canada, Canada
Anna Spreafico, MD, PhD
Recruiting

United States

University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Santanu Samanta, MD
Recruiting
University of California, Irvine
Irvine, California, United States
Bao-An Huynh
Recruiting
University of California, San Francisco
San Francisco, California, United States
Sue S Yom, MD
Recruiting
Emory Winship Cancer Institute
Atlanta, Georgia, United States
Dong Shin, MD
Recruiting
Boston Medical Center
Boston, Massachusetts, United States
Peter C Everett, MD
Recruiting
University of Michigan
Ann Arbor, Michigan, United States
Paul Swiecicki, MD
Recruiting
Henry Ford Cancer Center
Detroit, Michigan, United States
Matthew Wilkins, MD
Recruiting
Laura & Isaac Perlmutter Cancer Center at Nyu Langone Health
New York, New York, United States
Withdrawn
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
Trisha M Wise-Draper, M.D., Ph.D.
Recruiting
Cleveland Clinic
Cleveland, Ohio, United States
Tamara Sussman, MD
Recruiting
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Danh Pham, MD
Recruiting
Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Stuart Wong, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Carboplatin →Cisplatin →Gemcitabine →Toripalimab →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Nov 2024
Primary completion: 31 Dec 2027
Completion: 31 Dec 2027
Last update posted: 30 Jul 2026
Registered enrollment: 100
Registry id: NCT06457503

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.